ESMO Virtual Preceptorship on Prostate Cancer 2021
![ESMO-Virtual-Preceptorship-Prostate-Cancer-1000x250-October](/var/esmo/storage/images/media/esmo/meetings/2021/_preceptorships/images/esmo-virtual-preceptorship-prostate-cancer-1000x250-october/8519413-1-eng-GB/esmo-virtual-preceptorship-prostate-cancer-1000x250-october.jpg)
- Start date
- 28 Oct 2021
- End date
- 28 Oct 2021
- Location
- Virtual, CEST Time
Learning objectives
- To learn about fundamentals of epidemiology, natural history and diagnosis as contributing factors to heterogeneity in prostate cancer
- To understand essentials in the assessment and multidisciplinary treatment of prostate cancer
- To learn about advances in treatment and novel targets in prostate cancer
Accreditation
The programme of this virtual event has been accredited with 5 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Co-Chairs
- Karim Fizazi, France
- Silke Gillessen, Switzerland